rs143057250

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003865.3(HESX1):​c.385G>A​(p.Val129Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000937 in 1,601,096 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00097 ( 2 hom. )

Consequence

HESX1
NM_003865.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:5

Conservation

PhyloP100: 2.06

Publications

6 publications found
Variant links:
Genes affected
HESX1 (HGNC:4877): (HESX homeobox 1) This gene encodes a conserved homeobox protein that is a transcriptional repressor in the developing forebrain and pituitary gland. Mutations in this gene are associated with septooptic dysplasia, HESX1-related growth hormone deficiency, and combined pituitary hormone deficiency. [provided by RefSeq, Jul 2008]
HESX1 Gene-Disease associations (from GenCC):
  • septooptic dysplasia
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypothyroidism due to deficient transcription factors involved in pituitary development or function
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.029887676).
BP6
Variant 3-57198465-C-T is Benign according to our data. Variant chr3-57198465-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 267733.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000664 (101/152186) while in subpopulation NFE AF = 0.0011 (75/68014). AF 95% confidence interval is 0.000902. There are 0 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HESX1NM_003865.3 linkc.385G>A p.Val129Ile missense_variant Exon 3 of 4 ENST00000295934.8 NP_003856.1 Q9UBX0A1LQR0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HESX1ENST00000295934.8 linkc.385G>A p.Val129Ile missense_variant Exon 3 of 4 1 NM_003865.3 ENSP00000295934.3 Q9UBX0
HESX1ENST00000647958.1 linkc.385G>A p.Val129Ile missense_variant Exon 6 of 7 ENSP00000498190.1 Q9UBX0
HESX1ENST00000473921.2 linkc.358-170G>A intron_variant Intron 2 of 2 5 ENSP00000418918.1 C9J0A9

Frequencies

GnomAD3 genomes
AF:
0.000664
AC:
101
AN:
152068
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000810
AC:
202
AN:
249392
AF XY:
0.000815
show subpopulations
Gnomad AFR exome
AF:
0.000252
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00133
Gnomad OTH exome
AF:
0.000494
GnomAD4 exome
AF:
0.000966
AC:
1400
AN:
1448910
Hom.:
2
Cov.:
28
AF XY:
0.000909
AC XY:
656
AN XY:
721554
show subpopulations
African (AFR)
AF:
0.000242
AC:
8
AN:
33014
American (AMR)
AF:
0.000517
AC:
23
AN:
44512
Ashkenazi Jewish (ASJ)
AF:
0.00223
AC:
58
AN:
26046
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39528
South Asian (SAS)
AF:
0.000199
AC:
17
AN:
85398
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53346
Middle Eastern (MID)
AF:
0.000722
AC:
4
AN:
5544
European-Non Finnish (NFE)
AF:
0.00112
AC:
1234
AN:
1101602
Other (OTH)
AF:
0.000885
AC:
53
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000664
AC:
101
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.000686
AC XY:
51
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41518
American (AMR)
AF:
0.000392
AC:
6
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68014
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00110
Hom.:
0
Bravo
AF:
0.000786
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00187
AC:
16
ExAC
AF:
0.000791
AC:
96
Asia WGS
AF:
0.000289
AC:
1
AN:
3470
EpiCase
AF:
0.00131
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Septo-optic dysplasia sequence Uncertain:3Benign:1
Apr 28, 2009
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2016
Hehr Laboratory, Center for Human Genetics Regensburg
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Uncertain:2Benign:2
Feb 15, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pituitary hormone deficiency, combined, 1 Uncertain:1
Apr 28, 2009
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Amenorrhea Uncertain:1
Mar 08, 2021
Yale Center for Mendelian Genomics, Yale University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Septo-optic dysplasia sequence;C2750027:GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES Uncertain:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 129 of the HESX1 protein (p.Val129Ile). This variant is present in population databases (rs143057250, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of HESX1-related conditions (PMID: 36531499). ClinVar contains an entry for this variant (Variation ID: 267733). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Dec 24, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

HESX1-related disorder Benign:1
May 12, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
D;D
Eigen
Benign
0.15
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.61
.;T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.030
T;T
MetaSVM
Uncertain
0.48
D
MutationAssessor
Benign
0.075
N;N
PhyloP100
2.1
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.73
.;N
REVEL
Uncertain
0.49
Sift
Benign
0.070
.;T
Sift4G
Benign
0.11
.;T
Polyphen
0.92
P;P
Vest4
0.15
MVP
0.91
MPC
0.074
ClinPred
0.031
T
GERP RS
3.8
Varity_R
0.10
gMVP
0.38
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143057250; hg19: chr3-57232493; API